Loading...
XNASZTEK
Market cap86mUSD
Dec 24, Last price  
0.83USD
1D
-1.88%
1Q
10.76%
Jan 2017
30.72%
IPO
158.20%
Name

Zentek Ltd

Chart & Performance

D1W1MN
XNAS:ZTEK chart
P/E
—
P/S
4,180.72
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
8.35%
Rev. gr., 5y
%
Revenues
30k
-59.07%
000000000002,355339,66672,85529,816
Net income
-12m
L-18.80%
-147,951-1,242,022-1,039,298-2,351,960-3,524,807-3,015,706-4,197,806-2,840,621-1,564,521-2,428,153-1,534,348-3,868,650-38,694,048-14,414,266-11,703,990
CFO
-8m
L-37.86%
-37,741-1,084,560-1,317,792-1,640,185-2,385,803-1,246,360-1,681,810-1,710,072-999,855-1,183,545-1,356,386-1,794,683-7,988,872-12,956,870-8,051,589

Profile

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
URL
https://www.zentek.com/
IPO date
Dec 22, 2010
Employees
29
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
30
-59.07%
73
-78.55%
340
14,323.18%
Cost of revenue
11,052
13,508
12,691
Unusual Expense (Income)
NOPBT
(11,022)
(13,435)
(12,352)
NOPBT Margin
Operating Taxes
(100)
119
26,738
Tax Rate
NOPAT
(10,922)
(13,553)
(39,089)
Net income
(11,704)
-18.80%
(14,414)
-62.75%
(38,694)
900.20%
Dividends
Dividend yield
Proceeds from repurchase of equity
(296)
35,343
BB yield
0.24%
-12.58%
Debt
Debt current
650
1,127
1,100
Long-term debt
1,078
1,099
1,412
Deferred revenue
Other long-term liabilities
Net debt
(1,794)
(8,131)
(24,162)
Cash flow
Cash from operating activities
(8,052)
(12,957)
(7,989)
CAPEX
(320)
(2,273)
(3,986)
Cash from investing activities
1,881
(2,307)
(7,253)
Cash from financing activities
(665)
(1,054)
38,825
FCF
(5,884)
(25,087)
(22,329)
Balance
Cash
3,521
10,357
26,675
Long term investments
Excess cash
3,520
10,354
26,658
Stockholders' equity
9,484
49,940
34,549
Invested Capital
17,896
21,643
10,122
ROIC
ROCE
EV
Common stock shares outstanding
100,503
99,436
92,092
Price
1.20
-21.43%
1.53
-49.84%
3.05
46.63%
Market cap
120,815
-20.59%
152,137
-45.84%
280,881
60.72%
EV
119,021
163,563
256,718
EBITDA
(10,408)
(12,895)
(11,737)
EV/EBITDA
Interest
107
121
64
Interest/NOPBT